![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Curative Biotechnology, Inc. (Curative Biotech) is a development stage biomedical company focused on novel therapies for rare diseases. The Company is identifying, acquiring, and developing disease modifying therapeutic drug candidates with a concentration on rare disease indications. Curative Biote... Curative Biotechnology, Inc. (Curative Biotech) is a development stage biomedical company focused on novel therapies for rare diseases. The Company is identifying, acquiring, and developing disease modifying therapeutic drug candidates with a concentration on rare disease indications. Curative Biotech currently has ongoing programs in three (3) different therapeutic areas: degenerative eye disease, infectious disease, and neuro oncology. The Company is now concentrating its energy and resources on its degenerative eye disease platform, based on a worldwide exclusive license from the National Eye Institute (NEI) at the National Institutes of Health (NIH). The first therapeutic to be developed on this platform is a Metformin Reformulation targeting the treatment of intermediate and late-stage Age-Related Macular Degeneration (AMD) disease with the goal of being in the clinic in 2023 for a first in human trial of its metformin-based eye drop. The trial will be conducted under a Cooperative Research and Development Agreement (CRADA) with the NEI. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.00502 | 46.5677179963 | 0.01078 | 0.016 | 0.0097 | 108416 | 0.0112306 | CS |
4 | 0.00245 | 18.3520599251 | 0.01335 | 0.016 | 0.0097 | 89847 | 0.01265119 | CS |
12 | 0.0093 | 143.076923077 | 0.0065 | 0.0165 | 0.0065 | 166932 | 0.01222985 | CS |
26 | 0.00075 | 4.98338870432 | 0.01505 | 0.0169 | 0.0013 | 168667 | 0.01209371 | CS |
52 | -0.0132 | -45.5172413793 | 0.029 | 0.04 | 0.0013 | 181123 | 0.018349 | CS |
156 | -0.05645 | -78.1314878893 | 0.07225 | 0.077 | 0.0013 | 342797 | 0.02404482 | CS |
260 | -0.1302 | -89.1780821918 | 0.146 | 0.19 | 0.0013 | 430313 | 0.0493488 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions